ArticleHead & face medicine2025
Impact of the Covid-19 pandemic on odontogenic infections in maxillofacial surgery.
Article in Head & face medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bacterial Profile and Antibiotic Resistance in Oral and Maxillofacial Infections.Journal of clinical medicine · 2026Article
- Impact of the SARS-CoV-2 Pandemic on Oral and Maxillofacial Surgery Activity: A Seven-Year Retrospective Study from a Romanian Emergency Hospital.Medicina (Kaunas, Lithuania) · 2026Article
- Impact of the COVID-19 Pandemic on Odontogenic Abscess Clinical Patterns and Predictive Factors: A Retrospective Cross-Sectional Study.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigates the impact of the COVID-19 pandemic on the distribution, characteristics, and treatment of odontogenic infections (OI) in a cranio-maxillofacial hospital, comparing data from pre-covid (PC) and intra-covid (IC) periods. MATERIALS AND
methodsA retrospective analysis was conducted on 194 patients treated for OIs from February 2019 to January 2021. Patients were categorized into two cohorts: PC (02/2019 - 01/2020) and IC (02/2020 - 01/2021). Data collected included demographics, infection types, symptoms, pre-existing conditions, treatments, length of hospital stay, and time from symptom onset to treatment.
resultsThe IC cohort exhibited a significant increase in submandibular (13.9% to 26.7%) and floor of mouth abscesses (6.5% to 18.6%). Patients in the IC period were more likely to present with fever (69.8% vs. 36.1%, p < 0.001) and dyspnea (48.8% vs. 33.3%, p = 0.029). Additionally, there was an increase in multi-space infections (7.4% to 22.1%) and higher inflammatory markers, with leukocyte counts rising from 12.51 × 10^9/l to 15.41 × 10^9/l (p < 0.001). The mean length of stay in the hospital also increased significantly from 3.24 days to 8.01 days (p < 0.001).
conclusionThe COVID-19 pandemic has significantly altered the landscape of OIs in oral and maxillofacial surgery, leading to more severe presentations, prolonged treatment durations, and increased hospital admissions. These findings underscore the necessity for improved public health strategies to ensure timely access to dental care during health crises. Enhanced awareness and proactive management are essential to mitigate the long-term impact of the aforementioned disruptions on patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.